Publication of initiatives on animal welfare and alternative methods, as well as reports from the Japanese Society for Regenerative Medicine conference.
"INA NOTES June 2016 No.3" is a publication by Inari Research Co., Ltd., which conducts safety testing and efficacy pharmacology testing for the development of pharmaceuticals, medical devices, pesticides, food, and other chemical substances. This publication includes a report on participation in the 15th Annual Meeting of the Japanese Society for Regenerative Medicine, as well as research presentation reports from the 7th Annual Meeting of the Japanese Society for Safety Research, and information on the marmoset testing project, accompanied by graphs and photographs. [Contents] ■ Efforts towards animal welfare and alternative methods ■ Participation report: 15th Annual Meeting of the Japanese Society for Regenerative Medicine ■ Research presentation report: 7th Annual Meeting of the Japanese Society for Safety Research ■ Marmoset testing project for small primates - Report No. 3 - ■ Recent events, etc. *The downloadable version is a "digest version." If you would like the "full version," please feel free to contact us.
Inquire About This Product
basic information
【Publication Content (Excerpt)】 ■Latest Technology Information ・Utilization of Plasma Micro-Sampling (PMS) technology for small animals ■TOPICS ・Inari Research Spring Seminar - Learning about the chemical industry and safety evaluation - etc. *What you can download is the "Digest Version." If you would like the "Complete Version," please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the brochure or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is located in the nature-rich city of Ina, Nagano Prefecture, surrounded by two Alps, and has been serving our customers as a non-clinical trial contract research organization (CRO) for 50 years. Since 2022, we have become a member of the Shin Nippon Science Group, expanding and enhancing our contract testing items and analyses, and we can quickly respond to the procurement of various testing materials (such as animals). Non-Clinical Trial Business We accept safety and efficacy testing for pharmaceuticals, chemicals, pesticides, food, medical devices, and more. We conduct in vivo tests using small animals, rabbits, dogs, and monkeys, as well as in vitro tests using bacteria and cells, and various alternative method tests. Additionally, we specialize in the creation of SEND data required for FDA applications for new drugs, and we also undertake work related to SEND conversion and QC for data creation and conversion only. Our facility was the first in Japan to obtain full accreditation from AAALAC International (the Association for Assessment and Accreditation of Laboratory Animal Care International), and we are committed to international standards of animal welfare. We also propose tests necessary for various applications and registrations in compliance with regulations in different countries and regions.
![[Free Distribution] Corporate Information Magazine INA NOTES](https://image.mono.ipros.com/public/product/image/f0b/2000307779/IPROS1306628680951325337.jpg?w=280&h=280)
![[Market Report] Global Market for Point-of-Care Diagnostic Tests](https://image.mono.ipros.com/public/product/image/123/2000940437/IPROS17678327490617014341.jpeg?w=280&h=280)
